Stefan Sarafianos, University of Missouri-Columbia (IMAGE)

University of Missouri-Columbia

Stefan Sarafianos, University of Missouri-Columbia

Caption

Stefan Sarafianos, an investigator with the University of Missouri Bond Life Sciences Center recently was awarded $3 million from the National Institutes of Health to study the disease. Building on existing research, he and his team will work on the development of new drugs to treat HBV.

Credit

Roger Meissen, Bond Life Sciences Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.